Literature DB >> 29296710

Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma.

Jennifer J G Welch1, Cindy L Schwartz2, Meghan Higman3, Lu Chen4, Allen Buxton4, Jennifer A Kanakry5, Samir B Kahwash6, Robert E Hutchison7, Debra L Friedman8, Richard F Ambinder9.   

Abstract

Assay of cell-free DNA in blood offers an approach to assessment of tumor DNA. We sought to determine whether Epstein-Barr virus (EBV) DNA in cell-free blood is also a good surrogate for the presence of tumor DNA in children with Hodgkin lymphoma, as it is in adults, and whether it correlates with pediatric outcomes. Pediatric patients enrolled in a Children's Oncology Group trial (AHOD0031) were studied at baseline and at 8 days after the initiation of treatment. At baseline, EBV DNA in cell-free blood correlated with the presence of EBV in tumor, and EBV DNA 8 days after the initiation of therapy predicted inferior event-free survival. EBV DNA in cell-free blood warrants further investigation as a marker of inadequate tumor response in Hodgkin lymphoma. This trial was registered at www.clinicaltrials.gov as #NCT00025259.

Entities:  

Year:  2017        PMID： 29296710      PMCID： PMC5727814          DOI： 10.1182/bloodadvances.2016002618

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  19 in total

1.  Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.

Authors:  Y M Lo; L Y Chan; K W Lo; S F Leung; J Zhang; A T Chan; J C Lee; N M Hjelm; P J Johnson; D P Huang
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

2.  Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Authors:  Maher K Gandhi; Eleanore Lambley; Jacqueline Burrows; Ujjwal Dua; Suzanne Elliott; Peter J Shaw; H Miles Prince; Max Wolf; Kerrie Clarke; Craig Underhill; Tony Mills; Peter Mollee; Devinder Gill; Paula Marlton; John F Seymour; Rajiv Khanna
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

3.  Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.

Authors:  Debra L Friedman; Lu Chen; Suzanne Wolden; Allen Buxton; Kathleen McCarten; Thomas J FitzGerald; Sandra Kessel; Pedro A De Alarcon; Allen R Chen; Nathan Kobrinsky; Peter Ehrlich; Robert E Hutchison; Louis S Constine; Cindy L Schwartz
Journal:  J Clin Oncol       Date:  2014-10-13       Impact factor: 44.544

Review 4.  Liquid biopsies: genotyping circulating tumor DNA.

Authors:  Luis A Diaz; Alberto Bardelli
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

5.  Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.

Authors:  Mário Henrique M Barros; Gabriela Vera-Lozada; Fernando A Soares; Gerald Niedobitek; Rocio Hassan
Journal:  Int J Cancer       Date:  2011-12-21       Impact factor: 7.396

6.  Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.

Authors:  Jennifer A Kanakry; Hailun Li; Lan L Gellert; M Victor Lemas; Wen-son Hsieh; Fangxin Hong; King L Tan; Randy D Gascoyne; Leo I Gordon; Richard I Fisher; Nancy L Bartlett; Patrick Stiff; Bruce D Cheson; Ranjana Advani; Thomas P Miller; Brad S Kahl; Sandra J Horning; Richard F Ambinder
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

7.  The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.

Authors:  J M Kwon; Y H Park; J H Kang; K Kim; Y H Ko; B Y Ryoo; S S Lee; S I Lee; H H Koo; W S Kim
Journal:  Ann Hematol       Date:  2006-03-14       Impact factor: 3.673

8.  Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.

Authors:  Mary Jo Fackler; Zoila Lopez Bujanda; Christopher Umbricht; Wei Wen Teo; Soonweng Cho; Zhe Zhang; Kala Visvanathan; Stacie Jeter; Pedram Argani; Chenguang Wang; Jaclyn P Lyman; Marina de Brot; James N Ingle; Judy Boughey; Kandace McGuire; Tari A King; Lisa A Carey; Leslie Cope; Antonio C Wolff; Saraswati Sukumar
Journal:  Cancer Res       Date:  2014-04-15       Impact factor: 12.701

9.  Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.

Authors:  S Hohaus; M Giachelia; G Massini; G Mansueto; B Vannata; V Bozzoli; M Criscuolo; F D'Alò; M Martini; L M Larocca; M T Voso; G Leone
Journal:  Ann Oncol       Date:  2009-05-22       Impact factor: 32.976

10.  Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease.

Authors:  M A Vasef; O W Kamel; Y Y Chen; L J Medeiros; L M Weiss
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307
View more
  11 in total

1.  Does Size Matter? Comparison of Extraction Yields for Different-Sized DNA Fragments by Seven Different Routine and Four New Circulating Cell-Free Extraction Methods.

Authors:  Linda Cook; Kimberly Starr; Jerry Boonyaratanakornkit; Randall Hayden; Soya S Sam; Angela M Caliendo
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

2.  CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma.

Authors:  Meir Shamay; Jennifer A Kanakry; John S W Low; Netanel A Horowitz; Guy Journo; Anuj Ahuja; Yonatan Eran; Elinor Barzilai; Eldad J Dann; Jennifer Stone; Wan Lu Woo; Wen-Son Hsieh; Rena R Xian; Richard F Ambinder
Journal:  Blood Adv       Date:  2020-04-28

3.  Sensitive detection of DNA from Chlamydia trachomatis by using flap endonuclease-assisted amplification and graphene oxide-based fluorescence signaling.

Authors:  Chang Yeol Lee; Hyowon Jang; Hansol Kim; Yujin Jung; Ki Soo Park; Hyun Gyu Park
Journal:  Mikrochim Acta       Date:  2019-05-06       Impact factor: 5.833

4.  Ultrasensitive DNA detection based on target-triggered rolling circle amplification and fluorescent poly(thymine)-templated copper nanoparticles.

Authors:  Kwan Woo Park; Chang Yeol Lee; Bhagwan S Batule; Ki Soo Park; Hyun Gyu Park
Journal:  RSC Adv       Date:  2018-01-16       Impact factor: 4.036

Review 5.  Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker.

Authors:  Wai Kei Jacky Lam; Kwan Chee Allen Chan; Yuk Ming Dennis Lo
Journal:  J Pathol       Date:  2019-02-25       Impact factor: 7.996

6.  Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases.

Authors:  W K Jacky Lam; Peiyong Jiang; K C Allen Chan; Wenlei Peng; Huimin Shang; Macy M S Heung; Suk Hang Cheng; Haiqiang Zhang; O Y Olivia Tse; Radha Raghupathy; Brigette B Y Ma; Edwin P Hui; Anthony T C Chan; John K S Woo; Rossa W K Chiu; Y M Dennis Lo
Journal:  Nat Commun       Date:  2019-07-22       Impact factor: 14.919

7.  Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma.

Authors:  Bing Xia; Xi Wang; Ruifang Yang; Li Mengzhen; Kunpeng Yang; Li Ren; Suxia Li; Shuye Wang; Yizhuo Zhang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

8.  Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality.

Authors:  Sara R Selitsky; David Marron; Lisle E Mose; Joel S Parker; Dirk P Dittmer
Journal:  mSystems       Date:  2018-09-25       Impact factor: 6.496

9.  High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.

Authors:  Nathan D Montgomery; Cara Randall; Matthew Painschab; Ryan Seguin; Bongani Kaimila; Edwards Kasonkanji; Takondwa Zuze; Robert Krysiak; Marcia K Sanders; Avian Elliott; Melissa B Miller; Coxcilly Kampani; Fred Chimzimu; Maurice Mulenga; Blossom Damania; Tamiwe Tomoka; Yuri Fedoriw; Dirk P Dittmer; Satish Gopal
Journal:  Cancer Med       Date:  2019-11-29       Impact factor: 4.452

Review 10.  Advances in Lymphoma Molecular Diagnostics.

Authors:  Igor Age Kos; Lorenz Thurner; Joerg Thomas Bittenbring; Konstantinos Christofyllakis; Dominic Kaddu-Mulindwa
Journal:  Diagnostics (Basel)       Date:  2021-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.